$PRVB the current valuation is not even close to pricing in the rest of the pipeline either you're essentially getting that for free. The protect trial for recently diagnosed diabetics which is in Phase 3 and the Celiac indication with Amgen and there's also potential for Lupus here as well so I'm happy to hold this for quite some time and let them run the whole program out at some point this company becomes a massive Blockbuster winner.
  • 15
  • 7